Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study to Test whether RO7568282 is safe, what kind of effects it may have on the body and what the body's response is (including how fast the body takes up and gets rid of RO7568282), at different doses (taken once or multiple times, and taken with or without food) in healthy participants

Next Previous
Trial Profile

A Study to Test whether RO7568282 is safe, what kind of effects it may have on the body and what the body's response is (including how fast the body takes up and gets rid of RO7568282), at different doses (taken once or multiple times, and taken with or without food) in healthy participants

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 16 Sep 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs RO 7568282 (Primary)
  • Indications Parkinson's disease
  • Focus First in man; Pharmacokinetics
  • Sponsors Roche

Most Recent Events

  • 16 Sep 2025 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top